title: [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
abstract: OBJECTIVE
  To investigate the effect of isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities.
  
  
  METHODS
  Limb isolated hyperthermic perfusion chemotherapy was performed in 41 patients with malignant melanoma of the extremities, and then the primary lesions in 24 patients were removed at 14 - 21 days after chemotherapy. Tumor necrosis was examined by pathology.
  
  
  RESULTS
  Among the 41 patients, 40 cases were followed up for 6-113 months, and one was lost. There was no local recurrence in those patients. 29 cases were followed up for more than 3 years, and 26 of them were surviving. Forteen cases were followed up for more than five years, among them 9 cases were surviving. The 3-year and 5-year survival rates of the whole group were 95.0% and 70.0%, respectively. The average reduction of the tumor volume was 55.6% after perfusion. The pathological examination showed that tumor necrosis was 90% - 100% (complete response) in 21 cases (87.5%) and 60% - 89% (partial response) in 3 cases (12.5%).
  
  
  CONCLUSIONS
  The isolated limb hyperthermic perfusion chemotherapy is an effective treatment of limb malignant melanoma. It can significantly reduce the local recurrence rate, and improve the 5-year survival rate, prognosis and the quality of life of the patients.
authors: Department of Bone and Soft Tissue Oncology, Gansu Provincial Tumor Hospital, Lanzhou 730050, China.
authors: Jing
authors: J
authors: Li
authors: Ping
authors: P
authors: Wang
authors: Xiao-jun
authors: XJ
authors: Zhu
authors: Jin-gang
authors: JG
authors: Song
authors: Jian-min
authors: JM
authors: Song
mesh_terms: D000328:Adult; D000368:Aged; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D002945:Cisplatin / Q000008:administration & dosage*; D005121:Extremities; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D011788:Quality of Life; D012074:Remission Induction; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*; D015996:Survival Rate
chemical_list: D002945:Cisplatin